Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
3D Systems | DDD | Apr 29, 2024 | 3.45 | +0.58 |
3M | MMM | Apr 29, 2024 | 92.16 | +0.36 |
4D Molecular Therapeutics | FDMT | Apr 29, 2024 | 24.25 | +4.30 |
51Talk Online Education Group ADR | COE | Apr 29, 2024 | 6.69 | +1.21 |
5E Advanced Materials | FEAM | Apr 29, 2024 | 1.10 | -2.65 |
60 Degrees Pharmaceuticals | SXTP | Apr 29, 2024 | 0.24 | +0.17 |
7-10 Yr Trsy Bear 3X Direxion | TYO | Apr 29, 2024 | 15.26 | -1.42 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Apr 29, 2024 | 23.76 | +1.24 |
7-10 Yr Trsy Ishares | IEF | Apr 29, 2024 | 91.86 | +0.40 |
89bio | ETNB | Apr 29, 2024 | 8.53 | +3.27 |
8x8 | EGHT | Apr 29, 2024 | 2.38 | +4.85 |
908 Devices | MASS | Apr 29, 2024 | 5.75 | +1.50 |
99 Acquisition Group | NNAGU | Apr 29, 2024 | 10.61 | 0.00 |
99 Acquisition Group | NNAG | Apr 29, 2024 | 10.45 | +0.58 |
9F ADR | JFU | Apr 29, 2024 | 3.48 | +11.54 |
A SPAC I Acquisition Unit | ASCAU | Apr 29, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | Apr 29, 2024 | 11.14 | 0.00 |
A-Mark Precious Metals | AMRK | Apr 29, 2024 | 41.05 | +2.32 |
a.k.a Brands | AKA | Apr 29, 2024 | 13.25 | +3.92 |
A.O Smith | AOS | Apr 29, 2024 | 84.31 | +1.32 |
A10 Networks | ATEN | Apr 29, 2024 | 13.40 | -1.03 |
A2Z Smart Technologies | AZ | Apr 29, 2024 | 0.42 | +7.14 |
AAA - A Rated Corporate Bond Ishares | QLTA | Apr 29, 2024 | 46.29 | +0.35 |
Aadi Bioscience | AADI | Apr 29, 2024 | 1.86 | +6.29 |
AAON | AAON | Apr 29, 2024 | 93.85 | +2.96 |
AAR | AIR | Apr 29, 2024 | 69.21 | +1.38 |
Abacus Life | ABL | Apr 29, 2024 | 11.84 | -0.75 |
Abbott Laboratories | ABT | Apr 29, 2024 | 107.27 | -0.24 |
AbbVie | ABBV | Apr 29, 2024 | 161.52 | +1.19 |
AbCellera Biologics | ABCL | Apr 29, 2024 | 3.84 | +2.13 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.